CSF1R and neoplasm: Recent research indicated that blocking M-CSFR signaling impaired the differentiation of tumor-infiltrating monocytes into MHC-IIlow M2-like TAM and consequently shifted the M1/M2 TAM balance toward the antitumoral TAM phenotype (71).